Sigrid Narum
Papers
1
Total Citations
22
H-Index
1
About
Dr. Sigrid Narum is a leading clinical pharmacologist whose research focuses on the intersection of pharmacogenomics and cardiovascular medicine, particularly the optimization of anticoagulation therapy. Her most cited work, a 2008 study in patients with myocardial infarction, made a pivotal contribution by demonstrating how genetic variations in CYP2C9 and VKORC1 significantly influence warfarin dose requirements and INR stability. This landmark paper, with 22 citations, helped establish the clinical utility of genotype-guided dosing to reduce bleeding and thromboembolic risks. Dr. Narum’s research has been instrumental in moving pharmacogenomics from the laboratory to the bedside, providing a framework for personalized warfarin therapy that improves patient safety. Her work is widely recognized for bridging the gap between genetic discovery and practical clinical application, making her a respected authority in precision medicine for thrombotic disorders. Through her studies, she has advanced the understanding of how individual genetic profiles can predict drug response, ultimately contributing to safer, more effective anticoagulation management.
Research Focus
Key Achievements
Top Papers
- 1